van de Wal, D.; Elie, M.; Le Cesne, A.; Fumagalli, E.; den Hollander, D.; Jones, R.L.; Marquina, G.; Steeghs, N.; van der Graaf, W.T.A.; Husson, O.
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature. Cancers 2022, 14, 1832.
https://doi.org/10.3390/cancers14071832
AMA Style
van de Wal D, Elie M, Le Cesne A, Fumagalli E, den Hollander D, Jones RL, Marquina G, Steeghs N, van der Graaf WTA, Husson O.
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature. Cancers. 2022; 14(7):1832.
https://doi.org/10.3390/cancers14071832
Chicago/Turabian Style
van de Wal, Deborah, Mai Elie, Axel Le Cesne, Elena Fumagalli, Dide den Hollander, Robin L. Jones, Gloria Marquina, Neeltje Steeghs, Winette T. A. van der Graaf, and Olga Husson.
2022. "Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature" Cancers 14, no. 7: 1832.
https://doi.org/10.3390/cancers14071832
APA Style
van de Wal, D., Elie, M., Le Cesne, A., Fumagalli, E., den Hollander, D., Jones, R. L., Marquina, G., Steeghs, N., van der Graaf, W. T. A., & Husson, O.
(2022). Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature. Cancers, 14(7), 1832.
https://doi.org/10.3390/cancers14071832
